About Enovis
Enovis is a publicly listed company based in United States founded in 2022. Medical devices for bracing, surgery, and recovery are manufactured. The company has 7,370 employees. Enovis has completed 2 acquisitions, including Lima Corporate and Novastep. Its chief executive, as recorded, is Matthew L Trerotola. Its website enovis.com draws about 125 thousand monthly visits. Enovis offers products and services including Bracing and Supports and Surgical Implants. Its focus areas include Traditional Medical Devices. Its legal entity is Enovis Corporation.
Company details
Enovis was founded in 2022 and is headquartered in the United States. Medical devices and equipment are produced by the company for bracing and support of various body parts, surgical implants, and recovery tools. Solutions are offered for foot and ankle care, diabetic footwear, bone healing regeneration, and spinal fusion. Muscle stimulators, therapy systems, and associated healthcare products are also provided within the medical devices sector.
- Headquarters United States
- Employees 7,370
- Stage Public
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website enovis.com
- Social LinkedIn X Facebook Instagram
- Legal Name Enovis Corporation
- Annual Revenue$2.25 B (USD)6.66as on Dec 31, 2025
- Net Profit-$1.18 B (USD)-43.25as on Dec 31, 2025
- EBITDA$297.41 M (USD)5.78as on Dec 31, 2025
- Employee Count7,370
- Investments & AcquisitionsLima Corporate
& 1 more
Products & Services of Enovis
Enovis offers a comprehensive portfolio of products and services, including Bracing and Supports and Surgical Implants.
Bracing and supports for body parts like knees and ankles are offered to aid in protection and recovery processes.
Surgical implants for joints such as hips and shoulders are provided to restore movement and improve quality of life.
Funding Insights of Enovis
- Total Rounds 1
All 1 funding rounds of Enovis with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2023 | Post-IPO | – | – | – |
People of Enovis
414 people are tracked at Enovis (165 in leadership, 249 in team); the tracked headcount is 7,370.
| Name | Role | Group |
|---|---|---|
Matthew L Trerotola | CEO | Leadership |
Allison Johnson | Vice President, Global Human Resources | Leadership |
Ajit Jain | Head Of Cloud, Infrastructure & End User Compute | Leadership |
Andrea Smith | Vice President HRIS | Leadership |
Steven Brewster | General Manager | Leadership |
Jennifer Kelly | Director, International HR | Leadership |
Joshua Kupke | Senior Director, R&d Product Development | Leadership |
Peter Trenkle | Director Human Resources DACH | Leadership |
Claire Pinon | France & Benelux HR Director | Surgical - International | Foot & Ankle | Leadership |
Rachel Tata | Senior Director Of Global Learning And Development | Leadership |
Donald Singelyn | Vice President Healthcare Solutions Automation | Leadership |
Elisha Hough | Director Project Management Ra/qa | Leadership |
Luka Simetovic | General Manager Surgical Italy | Leadership |
Colleen Farrell | Sr. Talent Acquisition Partner | Leadership |
Rich Beverley | Regional Sales Director | Leadership |
Erwin Mascardo | Director Surgical PMO | Leadership |
Brady R. Shirley | President, CEO, & Director | Leadership |
Andrew Fox-Smith | President, International Business | Leadership |
Jim Pomeroy | VP, Quality Assurance & Regulatory Affairs | Leadership |
Bryan S. Mcmillan | President, Regeneration | Leadership |
394 more people are available in the full profile.
Complete people profiles for Enovis
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Enovis
Enovis is a publicly listed company on the NYSE with ticker symbol ENOV in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date05 Sep 2023
- Listed onB3: E2NO34
- Listed entityEnovis Corporation
- Exchange sectorHealth technology
- ISINUS1940145022
- Share price$18.99 (+4.05% on the day) · 2026-10-13
- Market capitalisation$1.10B
- EPS (diluted, trailing year)$-19.24
- Volume (last session)1,405,755
Financials of Enovis
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $2.25B | -$1.18B | $297.4M |
| 2024 | $2.11B | -$825.5M | $281.2M |
| 2023 | $1.71B | -$48.8M | $212.3M |
| 2022 | $1.56B | -$15.0M | $176.2M |
| 2021 | $1.43B | $62.6M | $163.8M |
Detailed financial statements for Enovis
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Enovis
Enovis has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Lima Corporate and Novastep.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Large joint primary and revision 3D printed implants for hip and knee, and fixation devices | limacorporate.com | Udine, Italy | 1945 | Sep 2023 | $851.48M | |
Medical devices for foot and ankle injuries are developed. | novastep.life | New York, United States | 2019 | Apr 2023 | •••• |
Complete acquisition details for Enovis
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Enovis
5 dated milestones of Enovis across 1 years, from founding to its latest funding, stage changes and deals.
- Founded Enovis is founded.
- Acquisition Acquires Novastep.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Lima Corporate.
- Funding First funding round.
Web traffic of Enovis
The website of Enovis (enovis.com) receives about 125.3K visits a month.
- Monthly visits125.3K
▲ 18.9% vs previous month
Websites whose visitors overlap most with Enovis. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
dme-direct.com | dme-direct.com | 100% | #706,261 | – | |
| graylinemedical.com | 98% | #238,989 | View details | ||
| mathysmedical.com | 97% | 9.7K | #2,283,947 | View details | |
orthobracing.com | orthobracing.com | 97% | #781,636 | – | |
| medicaldepartmentstore.com | 97% | #1,594,153 | View details | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 31 similar websites and full traffic analytics for Enovis
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 31 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Traditional Diagnostics & Medical Devices
3 companies that operate in the same segment as Enovis (Traditional Diagnostics & Medical Devices) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Materials management solutions are provided for healthcare organizations. | 1892 | Chicago, Illinois, United States | USD 29.13 M | USD 19.48 B | 95,424 | |
3D-printed orthopedic products are manufactured for medical applications. | 1941 | Kalamazoo, Michigan, United States | ||||
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | USD 5.1 B | 13,500 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Enovis
Complete news archive for Enovis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Enovis
Enovis was founded in 2022 and raised its 1st funding round 1 year after it was founded.
Enovis is headquartered in United States.
Matthew L Trerotola is the CEO of Enovis, as recorded in our data.
Enovis has 7,370 employees.
Annual revenue of Enovis is $2.25B as on Dec 31, 2025.
Enovis was founded in 2022 and is headquartered in the United States. Medical devices and equipment are produced by the company for bracing and support of various body parts, surgical implants, and recovery tools. Solutions are offered for foot and ankle care, diabetic footwear, bone healing regeneration, and spinal fusion. Muscle stimulators, therapy systems, and associated healthcare products are also provided within the medical devices sector.
Enovis offers Bracing and Supports and Surgical Implants.
Yes, Enovis is publicly traded on NYSE under the ticker symbol ENOV.
Enovis has made 2 acquisitions, including Lima Corporate, and Novastep.
Enovis operates through Enovis Corporation.
The website of Enovis receives about 125 thousand visits a month.